Synthesis and SAR of novel 1,1-dialkyl-2(1H)-naphthalenones as potent HCV polymerase inhibitors.
暂无分享,去创建一个
A. Molla | D. Kempf | H. Mo | T. Middleton | W. Kati | D. Hutchinson | Wen W. Jiang | Yaya Liu | R. Wagner | Todd D. Bosse | D. Montgomery | G. Koev | T. Rockway | D. Larson | Sherie V Masse | Wen W Jiang
[1] A. Molla,et al. Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1,8-naphthyridon-3-yl benzothiadiazine analogs containing substituents on the aromatic ring. , 2006, Bioorganic & medicinal chemistry letters.
[2] K. Naka,et al. Different anti‐HCV profiles of statins and their potential for combination therapy with interferon , 2006, Hepatology.
[3] A. Molla,et al. Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazines. , 2005, Bioorganic & medicinal chemistry letters.
[4] Paul A Keller,et al. Control of hepatitis C: a medicinal chemistry perspective. , 2005, Journal of medicinal chemistry.
[5] J. Hoofnagle. Course and outcome of hepatitis C , 2002, Hepatology.
[6] A. Goldfarb. New Compounds. Derivatives of 2,5-Diaminobenzenesulfonamide , 1943 .